FindTrial
Sign In

Effects of regional citrate anticoagulation on coagulation function and cardiac electrical activity in patients with liver failure treated with artificial liver support system

Effects of regional citrate anticoagulation on coagulation function and cardiac electrical activity in patients with liver failure treated with artificial liver support system

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056986
Enrollment
Unknown
Registered
2022-02-25
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

None listed

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. ACLF patients treated with DPMAS plus PE therapy with RCA; 2. Age 18-70 years.

Exclusion criteria

Exclusion criteria: 1. Patients with any tumor; 2. Patients received organ transplantation.

Design outcomes

Primary

MeasureTime frame
Coagulation function and electrocardiographic changes;—

Contacts

Public ContactYuanji Ma

West China Hospital of Sichuan University

maxe.doc@163.com+86 18980606465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026